dpp-4 inhibitor and glp-1 receptor agonist combination not recommended guideline DPP4 Inhibitors vs Agonists | June 2021 | Clinical Corner Role of DPP-4 Inhibitors in
Description
Importantly, large-scale randomized trials, meta-analyses, and observational studies suggest that GLP-1RAs do not significantly increase AKI risk and may even confer renal benefits in high-risk populations
What if it doesnt work for me?
These drugs have potent glucose-lowering actions and, additionally, lower body weight through satiety induction while reducing blood pressure and dyslipidemia
Is allulose a GLP-1 agonist
Check your GLP-1 receptor gene variants linked to weight loss response
